Sponsored by:

Nuclear Medicine: Page 141

FDG-PET/CT offers insight into thyroid cancer patient survival
By Wayne Forrest
Sunday, November 30 | 11:25 a.m.-11:35 a.m. | SSA18-05 | Room S505ABFDG-PET/CT scans conducted more than six months after primary thyroid cancer treatment can enhance a patient's clinical evaluation and provide a prognostic marker of overall survival, according to this study from Johns Hopkins University.
November 4, 2014
Lantheus inks Mo-99 supply deal with Shine
By AuntMinnie.com staff writers
Lantheus Medical Imaging has signed an agreement with Shine Medical Technologies covering the supply of molybdenum-99 (Mo-99).
November 3, 2014
Digirad urges PDI to reconsider offer
By AuntMinnie.com staff writers
Digirad has sent a letter to healthcare commercialization services company PDI urging it to reconsider an acquisition offer from Digirad that PDI summarily rejected within hours after receipt on October 29.
November 2, 2014
PDI rebuffs Digirad's acquisition offer
By AuntMinnie.com staff writers
Healthcare commercialization services company PDI has rebuffed an acquisition offer from nuclear medicine firm Digirad.
October 29, 2014
Digirad posts Q3 2014 financials
By AuntMinnie.com staff writers
Digirad saw revenue growth in its 2014 third quarter and nine-month period.
October 29, 2014
Sofie scores $1.5M NCI contract
By AuntMinnie.com staff writers
Molecular imaging developer Sofie Biosciences has received a two-year, $1.5 million contract from the U.S. National Cancer Institute (NCI).
October 21, 2014
Gamma Medica gets additional financing
By AuntMinnie.com staff writers
Molecular imaging developer Gamma Medica has secured new capital financing.
October 21, 2014
ABT adds $15M to coffers
By AuntMinnie.com staff writers
ABT Molecular Imaging said it has received $15 million in new financing.
October 20, 2014
Mediso launches PET/CT research scanner
By AuntMinnie.com staff writers
Mediso Medical Imaging Systems has launched its new MultiScan LFER 150 PET/CT scanner, dedicated to research applications in clinical and preclinical imaging.
October 19, 2014
Mallinckrodt warns of price hikes for Tc-99m
By AuntMinnie.com staff writers
Mallinckrodt is telling customers who receive its technetium-99m (Tc-99m) radioisotope to expect a series of price increases over the next few years.
October 16, 2014
Ground Fluor inks radiopharma license with MGH
By AuntMinnie.com staff writers
Ground Fluor Pharmaceuticals has signed an exclusive licensing agreement with Massachusetts General Hospital (MGH) for newly developed aryliodonium ylide chemistry.
October 16, 2014
Agilent to close nuclear MR business
By AuntMinnie.com staff writers
After four years of subpar performance, Agilent Technologies is shutting down its nuclear MR business.
October 15, 2014
Previous Page
Page 141 of 440
Next Page